M. Estiarte

发表

23 – STEREOCHEMICAL ASPECTS OF DRUG ACTION I: CONFORMATIONAL RESTRICTION, STERIC HINDRANCE AND HYDROPHOBIC COLLAPSE

D. Rich, M. A. Estiarte, A. Philip, 2003 .

A single‐step preparation of thiazolo[5,4‐b]pyridine‐ and thiazolo[5,4‐c]pyridine derivatives from chloronitropyridines and thioamides, or thioureas

M. Cox, M. Duncton, M. A. Estiarte, 2009 .

VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis.

E. Di Cera, K. Fox, C. Gibson, 2020, Thrombosis research.

Conformationally restricted analogues of methionine: Synthesis of chiral 3-Amino-5-methylthio-2-piperidones

A. Colell, J. Fernandez-Checa, C. Garcia-Ruiz, 1996 .

Preparation of heteroaryloxetanes and heteroarylazetidines by use of a Minisci reaction.

M. Cox, M. Duncton, M. A. Estiarte, 2009, The Journal of organic chemistry.

Preparation of aryloxetanes and arylazetidines by use of an alkyl-aryl suzuki coupling.

M. Cox, M. Duncton, M. A. Estiarte, 2008, Organic letters.

2-Amino-5-arylbenzoxazole derivatives as potent inhibitors of fatty acid amide hydrolase (FAAH)

D. Emerling, M. Duncton, D. J. R. O'mahony, 2012 .

Synthesis and synthetic applications of 3-amino-Δ5-piperidein-2-ones: Synthesis of methionine-derived pseudopeptides

M. Rubiralta, M. A. Estiarte, A. Diez, 1999 .

Discovery of nonpeptide, peptidomimetic peptidase inhibitors that target alternate enzyme active site conformations.

D. Rich, M. Bursavich, M. A. Estiarte, 2002, Biopolymers.

Reversible covalent direct thrombin inhibitors

E. Di Cera, M. Sivaraja, N. Pozzi, 2018, PloS one.

Discovery of novel N-acylpyrazoles as potent and selective thrombin inhibitors.

E. Di Cera, N. Pozzi, M. A. Estiarte, 2022, European journal of medicinal chemistry.

Preparation of aryloxetanes and arylazetidines by use of an alkyl-aryl suzuki coupling.

M. Cox, M. Duncton, D. J. R. O'mahony, 2008, Organic letters.